The Alveolar Epithelium and Pulmonary Fibrosis

Abstract

Idiopathic interstitial pneumonias (IIPs) are a heterogeneous group of diffuse pulmonary parenchymal diseases that are comprised of seven distinct clinical and pathological entities. Idiopathic pulmonary fibrosis (IPF) and cryptogenic organizing pneumonia (COP) represent two of the most prevalent members of the disease group with major differences in their pathogenesis, clinical course and prognosis. IPF is a refractory and lethal IIP characterized by fibroblast proliferation, deposition of extracellular matrix (ECM) and progressive lung scarring. The incidence of IPF is estimated at 15 to 40 cases per 100,000 per year, and the mean survival from the time of diagnosis is 3 to 5 years regardless of treatment. While its pathogenesis is incompletely understood, the currently accepted paradigm proposes that injury of the alveolar epithelium is followed by a burst of pro-inflammatory and fibroproliferative mediators that invoke responses associated with dysregulated repair of the damaged alveolar epithelium. Recently, there have been studies suggesting that the activation of the alveolar epithelial cells (AECs) may play an active role in the pathogenesis of pulmonary fibrosis. Here, we review the advances in recent studies on the role of the alveolar epithelium in pulmonary fibrosis. AECS: A BRIEF OVERVIEW OF STRUCTURE AND PHYSIOLOGICAL FUNCTIONSTwo types of AECs populate the alveolar epithelium in normal adult lungs, alveolar epithelial type I (AT I) and alveolar epithelial type II (AT II) cells. AT I pneumocytes comprise 40% of the AECs and cover 90% of the internal surface area of the lung. AT I cells are highly attenuated and form an interface with pulmonary capillaries that are intimately involved in gas exchange. These cells also take part in peptide and amino acid transportation across the lung by pinocytosis and transporter-mediated transport [1]. Recently, AT I cells have been shown to be also important in the transportation of water and sodium across the lung [2,3].AT II cells, on the other hand, AT II cells make up 16% of the parenchymal cells in the lung and account for only 5% of the alveolar surface. These cells are cuboidal cells that are situated between AT I cells and they contain characteristic lamellar bodies and apical microvilli. AT II cells synthesize, store and secrete the pulmonary surfactant (PS), which consists of lipids and their associated proteins and whose function is to reduce the surface tension of the lung alveolus and prevent it from collapse or overdistension with respiration. AT II cells also regulate alveolar fluid balance in normal lungs and during the resolution of pulmonary edema [4] and the pathogenesis of acute lung injury with pulmonary edema is associated with an insufficient number of AT II cells and transportation of water into the lung alveolus. Recently, AT II cells have been shown to synthesize and secrete immunomodulatory proteins important for host defense, including surfactant proteins A (SP-A) and D (SP-D) [5]. SP-A can combine with lipid A in the lipopol...

KIF7 Controls the Proliferation of Cells of the Respiratory Airway through Distinct Microtubule Dependent Mechanisms

“…The alveolar epithelium needs to be maintained throughout life as it can be damaged by pathogens, environmental toxins, and various disease processes [ 1 , 2 ]. When the alveolar epithelium is damaged, these cell populations need to be replenished to maintain proper lung function [ 3 ].…”

Earthworm extract attenuates silica-induced pulmonary fibrosis through Nrf2-dependent mechanisms

“…In the most severely damaged alveolar epithelium, the denuded basement membrane is covered by proliferating AT II cells, and there is an apoptosis in AT II cells with massive infiltration by fibroblasts and myofibroblasts, leading to an abnormal wound healing pathway, and finally excessive deposition of extracellular matrix around the damaged epithelium. 36 Recent evidence reported that caspase inhibitors 37 or the genetic deletion of apoptosis signaling molecules 38 blocked fibrogenesis. In line, in the model of bleomycin-induced pulmonary fibrosis, intratracheal instillation of a purified population of syngeneic AT II cells was sufficient to block fibrotic lung remodeling.…”